EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, Docking Studies and Molecular Dynamics Simulation of New 1,3,5‐Triazine Derivatives as Anticancer Agents Selectively Targeting Pancreatic Adenocarcinoma (Capan‐1)

Shazia Asghar, Shahid Hameed iD, Najim A Al-Masoudi iD, Bahjat Saeed, Amneh Shtaiwi

Chemistry & Biodiversity · 2024

DOI: 10.1002/cbdv.202400112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Shazia Asghar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Quaid-I-Azam University, Islamabad, 45320, Pakistan. Hauptthemen laut MEDLINE: Antineoplastic Agents, Triazines, Molecular Docking Simulation, Molecular Dynamics Simulation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

On the basis of remarkable anticancer profile of s ‐triazine nucleus, a new series of 2‐methoxy‐4‐(3‐morpholino‐5‐(arylamino)phenoxy)benzaldehyde derivatives 11 a – u was prepared and evaluated for in vitro antiproliferative activity against eight diverse human cancer cell lines (Capan‐1, HCT‐116, LN229, NCI‐H460, DND‐41, HL‐60, K562 and Z138). Compounds 11 o , 11 r and 11 s were the most potent anticancer agents on pancreatic adenocarcinoma (Capan‐1) cell line with IC 50 value of 1.4, 5.1 and 5.3 μM, respectively, while compounds 11 f, 11 g , 11 k , 11 l and 11 n displayed selective activity against the pancreatic adenocarcinoma (Capan‐1) cell line with IC 50 values of 7.3–11.5 μM. These results indicate that derivative 11 o may serve as a promising lead compound for the ongoing development of novel antiproliferative agents. The docking studies were conducted to predict the interactions of derivative 11 o with putative protein targets in pancreatic adenocarcinoma (Capan‐1) cell line, specifically the prenyl‐binding protein PDEδ. Furthermore, the analysis of the molecular dynamics simulation results demonstrated that complex 11 o promoted a higher stability to the prenyl‐binding protein PDEδ.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsTriazinesMolecular Docking SimulationMolecular Dynamics SimulationPancreatic NeoplasmsDrug DesignDrug Screening Assays, AntitumorCell ProliferationAdenocarcinomaHumansCell Line, TumorStructure-Activity RelationshipMolecular StructureDose-Response Relationship, Drug

Stichwörter der Autor:innen

anticancer activitydocking studymolecular dynamics simulationprenyl-binding protein (PDEδ)s-triazine derivatives

Substanzen

Antineoplastic AgentsTriazines

Autor:innen und Institutionen

  • Department of Chemistry, Quaid-I-Azam University, Islamabad, 45320, Pakistan.
  • Department of Chemistry, College of Science, University of Basrah, Basrah, 61001, Iraq.
  • A Tannenhof 8, 78464, Constanz, Germany.
  • Department of Chemistry, College of Education for Pure Science, University of Basrah, Basrah, 61001, Iraq.
  • Faculty of Pharmacy, Middle East University, Queen Alia Airport Street, 11610, Amman, Jordan.

ORCID-Profile: Shahid Hameed, Najim A Al-Masoudi

Zitieren

APA

Asghar, S., Hameed, S., Al-Masoudi, N. A., Saeed, B., & Shtaiwi, A. (2024). Design, Synthesis, Docking Studies and Molecular Dynamics Simulation of New 1,3,5‐Triazine Derivatives as Anticancer Agents Selectively Targeting Pancreatic Adenocarcinoma (Capan‐1). Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202400112

Vancouver

Asghar S, Hameed S, Al-Masoudi NA, Saeed B, Shtaiwi A. Design, Synthesis, Docking Studies and Molecular Dynamics Simulation of New 1,3,5‐Triazine Derivatives as Anticancer Agents Selectively Targeting Pancreatic Adenocarcinoma (Capan‐1). Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202400112

BibTeX
@article{Asghar2024,
  author = {Asghar, Shazia and Hameed, Shahid and Al-Masoudi, Najim A and Saeed, Bahjat and Shtaiwi, Amneh},
  title = {Design, Synthesis, Docking Studies and Molecular Dynamics Simulation of New 1,3,5‐Triazine Derivatives as Anticancer Agents Selectively Targeting Pancreatic Adenocarcinoma (Capan‐1)},
  journal = {Chemistry & Biodiversity},
  year = {2024},
  doi = {10.1002/cbdv.202400112}
}
Kostenlos starten →